• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Cancer Diagnostics

Daymark Health Launches with $11.5M to Redefine Cancer Care

by Fred Pennic 04/03/2025 Leave a Comment

Daymark Health Launches with $11.5M to Redefine Cancer Care

What You Should Know:  - Daymark Health, a company aiming to redefine the cancer care experience, has publicly launched with an $11.5M in seed funding co-led by Maverick Ventures and Yosemite, with additional participation from Oncology Ventures.  Daymark was launched out of Healthcare Foundry, with Robert Pahlavan and Jonathan Rhodes as co-founders leading thesis development. - The company began operations this year in partnership with a leading payer in the Northeast, providing
Read More

AI Accelerates Cancer Research: ACS Partners with Layer Health for LLM Data Extraction

by Jasmine Pennic 03/13/2025 Leave a Comment

American Cancer Society and Yosemite Award $6M in Research Grants to Innovative Cancer Scientists

What You Should Know:  - The American Cancer Society (ACS) and Layer Health, an innovator in AI-driven healthcare technology, have announced a multi-year collaboration aimed at accelerating cancer research. This partnership will leverage large language models (LLMs) to streamline the extraction of vital clinical data from patient medical records. - This collaboration builds upon a successful pilot program that focused on breast cancer patients. The pilot demonstrated the platform's
Read More

Paige Expands PanCancer Detect to Identify Cancer in Over 40 Tissue Types

by Fred Pennic 02/06/2025 Leave a Comment

What You Should Know:  - Paige, a provider of AI-powered pathology solutions, today announced a significant expansion of Paige PanCancer Detect, its groundbreaking cancer detection tool.  - Originally launched in 2024 with the ability to identify cancer in 17 tissue types, PanCancer Detect now supports over 40 tissue and organ types, thanks to advancements in Paige's AI foundation models. AI-Powered Pathology Solution Enhances Diagnostic Accuracy and Efficiency This
Read More

Color Health Report Reveals Gaps in Employer Cancer Benefits

by Fred Pennic 02/05/2025 Leave a Comment

Color Health Report Reveals Gaps in Employer Cancer Benefits

What You Should Know:  - Color Health, a provider of precision health solutions released its second annual Employer Insights Report, revealing a disconnect between employer priorities and the reality of cancer care benefits offered to employees.  - The survey, conducted by The Harris Poll, explores how benefits leaders make decisions regarding cancer program benefits, including their current offerings, perceived effectiveness, and strategies for managing costs. Disconnect
Read More

Oatmeal Health Unveils AI Diagnostic Platform for Lung Cancer Screening in Underserved FQHC Communities

by Fred Pennic 01/31/2025 Leave a Comment

Oatmeal Health Unveils AI Diagnostic Platform for Lung Cancer Screening in Underserved FQHC Communities

What You Should Know:  - Oatmeal Health, an innovator in AI-driven cancer screening launches its AI-powered radiology risk stratification platform for lung cancer.  - The solution provides a fully reimbursable second-opinion diagnostic tool covered by Medicare, making it more accessible and affordable for healthcare providers and patients. AI-Powered Lung Nodule Analysis Lung cancer remains a leading cause of cancer-related deaths worldwide, but screening rates remain
Read More

Owkin Doses First Patient in Phase I Trial of AI-Optimized Cancer Therapy OKN4395

by Jasmine Pennic 01/31/2025 Leave a Comment

Owkin Doses First Patient in Phase I Trial of AI-Optimized Cancer Therapy OKN4395

What You Should Know:  - Owkin, an AI-powered biotech company, today announced the dosing of the first patient in its Phase I clinical trial of OKN4395, a novel cancer therapy designed to restore immune function in patients with advanced solid tumors.  - OKN4395 represents a novel approach to cancer treatment by targeting multiple immunosuppressive pathways simultaneously.  OKN4395 Background OKN4395 is a first-in-class asset that selectively inhibits three
Read More

Owkin, Proscia Partner to Streamline MSI Testing for Colorectal Cancer

by Fred Pennic 11/19/2024 Leave a Comment

Owkin, Proscia Partner to Streamline MSI Testing for Colorectal Cancer

What You Should Know:  - Owkin, an AI-biotech company specializing in precision medicine, and Proscia, a leader in AI-enabled pathology solutions, have announced a strategic partnership to improve MSI testing for colorectal cancer (CRC). This collaboration aims to enhance the efficiency and accessibility of MSI screening, ultimately leading to better patient outcomes. - Beyond MSI testing, Owkin and Proscia plan to collaborate on developing and commercializing additional AI solutions
Read More

AI Against Cancer: Capabilities and Limitations for Early Detection and Treatment Planning

by Gala Batsishcha, Healthcare IT Consultant at ScienceSoft 11/11/2024 Leave a Comment

AI Against Cancer: Capabilities and Limitations for Early Detection and Treatment Planning

The American Cancer Society predicted 2 million new cancer cases in the US alone in 2024, which amounts to roughly 5,480 diagnoses every day. What makes matters worse is that the pandemic delayed care for more than 75% of cancer patients. Unsurprisingly, healthcare providers are turning to new technologies like AI in search of solutions. To gauge the magnitude of this trend, consider this: as of August 7, 2024, 950 AI/ML-enabled medical devices have received clearance from the FDA, with 76% of
Read More

miRoncol Develops Multi-Cancer Early Detection Blood Test

by Fred Pennic 10/16/2024 Leave a Comment

miRoncol Develops Multi-Cancer Early Detection Blood Test

What You Should Know:  - miRoncol, a medtech startup, has announced the completion of proof-of-concept studies for a groundbreaking multi-cancer early detection blood test.  - The test utilizes microRNA analysis and machine learning, two technologies recognized by the 2024 Nobel Prizes, to identify cancers at their earliest stages, even before the onset of noticeable symptoms. The Power of microRNA and Machine Learning MicroRNAs (miRNAs) are small RNA molecules that play a
Read More

MedCognetics Unveils Embedded AI Cancer Detection System for Mammography Imaging

by Syed Hamza Sohail 10/10/2024 Leave a Comment

MedCognetics Unveils Embedded AI Cancer Detection System for Mammography Imaging

What You Should Know: -  MedCognetics, Inc., a company focusing on medical imaging AI, today announced the successful testing and implementation of the first embedded AI image processing and cancer detection system for mammography. -  The system utilizes the NVIDIA IGX OrinTM medical-grade edge AI platform alongside MedCognetics’ advanced AI-enabled software, CogNet AI-MT, which was developed in collaboration with clinical leaders worldwide. CogNet AI-MT has been trained on a diverse
Read More

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 6
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |